InsidersTradesSigma
Track the 20/20 Biolabs, Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). The latest transaction was filed on 23 February 2026 (C). Among the most active insiders: Rollins John Woodson. The full history is accessible without an account.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 February 2026
Declarations4 total
13,029 shares0Common StockSEC:0001213900-26-019456:0
31 shares0Common StockSEC:0001213900-26-019424:0
7,669 shares0Common StockSEC:0001213900-26-019423:0
7,700 shares0Common StockSEC:0001213900-26-019421:0
4 of 4 declarations
Acerca de 20/20 Biolabs, Inc.
20/20 Biolabs, Inc. es una empresa de biotecnología enfocada en el desarrollo de soluciones innovadoras para investigación y aplicaciones médicas. Cotiza en el mercado XNAS.